About Us - Ceylon Biomedical

Experts in precision cannabis medicines.

We produce the highest quality chemotype-selected extracts - available in a variety of crude and purified dosage forms.

Ceylon Biomedical is led by a cross-specialty team of experts in genetics, cultivation, and medical research. With deep scientific expertise and strict adherence to EU-GMP standards, we produce high-purity APIs and finished dosage forms designed for safety, consistency, and therapeutic efficacy. Our work supports the advancement of evidence-based cannabis medicine, with a global reach across regulated markets in Europe, Asia, and the Americas.

Meet our team

Our team of industry-leading experts combines deep scientific knowledge and clinical experience to advance the therapeutic potential of medical cannabis.

Dr. Hans Keirstead

Medical Scientist, Serial Biotech Entrepreneur

A globally recognized neuroscientist, stem cell expert and serial entrepreneur known for pioneering therapies in cancer, infectious disease, retinal disease, spinal cord injury, and immune disorders. Founded 5 successful biotech companies, currently Chairman of Immunis and AIVITA Biomedical. His work bridges advanced science with successful biotech commercialization.

Professor Nephi Stella

Professor of Pharmacology and Psychiatry

A Professor of Pharmacology and Psychiatry at the University of Washington and a leading expert in cannabinoid research. He founded the UW Center for Cannabis Research and has held continuous NIH funding since 1999. His work spans drug discovery, neuroscience, and the therapeutic applications of cannabinoids, with over 120 publications and multiple patents.

Thushi Radella

CEO and Managing Director of Premium International Injectable PVT LTD

Leads several of the leading and agricultural initiatives in Sri Lanka. Maintains influential relationships with all levels of government, to enhance national development of pharmaceutical, medical, agricultural and cultural sectors.

Todd Boren

Founder, CEO of Alpen Group

Founded one of the first US Cannabis Funds and MacArthur Fund; between 2015 – 2019 deployed more capital in the industry than any other. This led to the largest exit at its time by selling Form Factory to Acreage Holdings. Previously the Managing Principal of International Assets Advisory and the Pinnacle Financial Group.

Peter Glik

Chief Commercial Officer, Alpen Group

Tristan Castillo

Chief Technical Officer, Alpen Group

10+ years experience in Cannabis and Pharma. Previously at MediPharm Labs growing company from pre-revenue to over 100mm in sales, creating and registering new cannabinoid-based drugs and providing expertise for multiple clinical trials for cannabinoid medicines.

Albert Grigorian

Chief Cultivation Officer, Alpen Group

Albert is a veteran cultivator with deep roots in California’s most competitive cannabis markets. Known for his precision in large-scale indoor operations, he consistently delivers premium-grade flower at commercial scale. His expertise spans facility design, cultivation strategy, and team leadership.

Matt Costa

CEO of Wonderbrett

Matt Costa is the co-founder and CEO of Wonderbrett, a legacy California brand celebrated for its elite genetics and connoisseur-quality flower. With decades of breeding and phenohunting experience, Matt has curated some of the market’s most iconic terpene profiles. His commitment to genetic excellence drives Wonderbrett’s global recognition and loyal following.